REGEN BIOPHARMA, INC. Convertible Debt
REGEN BIOPHARMA, INC. (RGBP) had Convertible Debt of $350.00 thousand as of 2019-12-16, per its 10-Q filed 2025-05-28.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2025-05-28
- 2019-12-16: Convertible Debt $350.00K.
| Period end | Convertible Debt |
|---|---|
| 2019-12-16 | $350.00K 10-Q · filed 2025-05-28 |